SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Techniclone (TCLN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
3702 23 0 TCLN
Emcee:  cjgaddy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3552 LYM-1 and LYM-11 are completely different antibodies that target different antiTerry D.-5/15/2000
3551 April 30 By PENNI CRABTREE The Orange County Register Techniclone Corp. is rTerry D.-4/30/2000
3550 OXiGENE, Inc. Invites You to Join Its First Quarter Financial Results ConferencAurumRabosa-4/26/2000
3549 FWIW, Looks like TNT for glioblastoma has some competition from NBIX. This is fJim Oravetz-4/19/2000
3548 I've been busy, almost finished with the spring planting though. Looks likEZLibra-4/19/2000
3547 For years there has been talk of using TNT as an imaging agent. This additionashero-4/19/2000
3546 Techniclone Expands VTA Patent Position Company Receives Broad Coverage of VTA Terry D.-4/19/2000
3545 New patent approved Compositions for targeting the vasculature of solid tumorsTerry D.-4/18/2000
3544 Interesting article: As far as biotech stocks go, the company's product liTerry D.-4/18/2000
3543 I had bought again at 4.75 earlier in the week. I would say that the fundaTadsamillionaire-4/16/2000
3542 I've already bought twice in the last month. So much for market timing. *L*Terry D.-4/14/2000
3541 Is TCLN a buy at these prices? Have some fundamentals within Techniclone changenzlsixty-4/14/2000
3540 For those new to this stock. Techniclone is more than a cancer biotech company.Terry D.-4/8/2000
3539 Publishing ID: 2458 IN VITRO AND IN VIVO STUDIES OF VEGF121/rGEL FUSION TOXINTerry D.-4/7/2000
3538 Presentation at AACR by Epstein's students. #1 Publishing ID: 1240 AntiboTerry D.-4/6/2000
3537 From our VTA description link on our website: Intellectual Property TechnicloTerry D.-4/5/2000
3536 Here's the Phase I results I mentioned, from AACR... OXiGENE Announces ProEZLibra-4/5/2000
3535 Nice OxiGene plug on CBS Evening news cbsnews.cbs.com 10 out of 27 responses EZLibra-4/5/2000
3534 Thank you Terry for all the info on Scotia.Nice to have a chat room with real ikmax-4/4/2000
3533 Sounds like Scotia will compete with C225 from IMCL in head and neck cancer. InEZLibra-4/4/2000
3532 Foscan Clinical Update, Announcement of Four Further Cancer Indications for FosTerry D.-4/4/2000
3531 Lilly connection? Board Appointment at Scotia Issue No 70 Scotia HoldingTerry D.-4/4/2000
3530 Important factor in the new agreement. news from Scotia: Foscan Accepted fTerry D.-4/4/2000
3529 roger, the exclusive part only applies to the Scotia product. Other companies sTerry D.-4/4/2000
3528 I'm a little concerned about the "exclusive" part of this agreemeRoger Mathias-4/4/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News